86. Pulmonary arterial hypertension Clinical trials / Disease details

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03638908 (ClinicalTrials.gov)	November 2013	12/7/2018	Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial	A Phase 2, Open-label, Clinical Trial of Fluoxetine, a Selective Serotonin Reuptake Inhibitor, in the Treatment of Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: Fluoxetine	University of Texas Southwestern Medical Center	NULL	Completed	16 Years	80 Years	All	8	Phase 2	United States
2	NCT00942708 (ClinicalTrials.gov)	September 2009	19/7/2009	Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension	Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: Fluoxetine	University of Texas Southwestern Medical Center	National Center for Research Resources (NCRR)	Completed	16 Years	75 Years	All	6	Phase 2	United States